TSS
ACXP icon

Two Sigma Securities’s Acurx Pharmaceuticals ACXP Stock Holding History

Two Sigma Securities’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-505
Closed -$15.2K – 2970
2023
Q3 		$15.2K Buy
+505
New +$19.3K ﹤0.01% 2621

Other funds holding ACXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Securities's ACXP Position: Q4 2023 in Review

Two Sigma Securities sold out of Acurx Pharmaceuticals (ACXP) in Q4 2023, closing a stake of 505 shares — an estimated $15.2K sold.

Two Sigma Securities first reported a position in ACXP in Q3 2023 and held it in 1 quarter. The position peaked at $15.2K in Q3 2023. 23 funds tracked by Wall St. Rank hold ACXP as of Q4 2023.

  • Two Sigma Securities reported no remaining Acurx Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Securities sold 505 Acurx Pharmaceuticals shares in Q4 2023, an estimated $15.2K.
  • Two Sigma Securities first reported a position in Acurx Pharmaceuticals in Q3 2023 and held it in 1 quarter.
  • Two Sigma Securities's Acurx Pharmaceuticals position peaked at $15.2K in Q3 2023.
  • 23 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.